The Park collaborates on a project for mass COVID-19 testing service led by IBEC, IRB Barcelona and CNAG-CRG Blog Post

The Government of Catalonia has approved the creation of the Orfeu Programme with the aim of having new diagnostic tests for COVID-19, as a complement to the capacity of the health system. In an initial phase, there will be two mass testing sites: one at the Barcelona Science Park, jointly coordinated by the Institute for Bioengineering of Catalonia (IBEC), the Institute for Research in Biomedicine (IRB Barcelona) and the Centro Nacional de Análisis Genómico (CNAG-CRG); and another coordinated by the Centre for Genomic Regulation (CRG) at its labs at the Barcelona Biomedical Research Park (PRBB).

 

Nostrum Biodiscovery appoints Ezequiel Mas as its new CEO and embarks on an ambitious expansion plan Blog Post

Nostrum Biodiscovery (NBD) has appointed Ezequiel Mas del Molino as its new CEO to lead a new phase of the company, which is establishing a leading position in the European market as a provider of cutting-edge bioinformatics technologies for drug design and discovery. NBD –a spin-off from the Institute for Research in Biomedicine (IRB Barcelona), the Barcelona Supercomputing Centre (BSC-CNS), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA)– is located at the Barcelona Science Park and the North Campus of the Universitat Politècnica de Catalunya (UPC).

 

IRB Barcelona collaborates with Amazon to develop a computational tool speeding up research against SARS-CoV-2 Blog Post

IRB Barcelona’s Structural Bioinformatics and Network Biology Laboratory, led by ICREA researcher Patrick Aloy at the Barcelona Science Park, has joined forces with Amazon Sciences to develop a computational tool, using artificial intelligence, that generates a open access database that includes all the published scientific results related to the treatment of SARS-CoV-2.

 

The PCB’s scientific community joins the fight against SARS-CoV-2 Blog Post

In response to the health emergency caused by SARS-CoV-2, research centres and biotech companies in the Barcelona Science Park (Parc Científic de Barcelona, PCB) are leading scientific progress in the treatment, vaccination and diagnosis of the novel coronavirus. The PCB will ensure that public centres and businesses can continue with their research projects by providing the resources and services they need.

 

Identified a new repairing mechanism of the peripheral nervous system by applyting bioengineering techniques Blog Post

A research group at the Institute of Bioengineering of Catalonia (IBEC) at the Barcelona Science Park has applied a new light-stimulated technique to modulate muscular activity and stimulate cell regeneration of the peripheral nervous system. Thanks to this research, published in Cells, the scientists have discovered that muscle activity can activate the neurons and accelerate their regeneration after an injury. 

 

Núria Montserrat wins Íñigo Álvarez de Toledo Award for Basic Research Blog Post

Núria Montserrat, ICREA research professor and principal investigator of the “Pluripotency for organ regeneration group” at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park, has unanimously won the XXXI Íñigo Álvarez de Toledo Award for Basic Research granted by the Fundación Renal Íñigo Álvarez de Toledo (FRIA).